Our Guiding Principles
As a world leading company in artificial heart technology, integrity and excellence are fundamental to Ventracor Limited.
We understand the great potential our research and business activities hold for millions of people worldwide who suffer congestive heart failure.
We place the dignity, wellbeing, safety and privacy of all patients who receive the VentrAssist™ before any other consideration.
Ventracor has adopted the following principles to guide its application of the VentrAssist™ for the benefit of patients, their families, medical staff, shareholders and the community:
Human trials
| 1. |
We will pursue medical technology in line with the highest medical, ethical and safety standards, protocols, guidelines, our company values as well as our legal and ASX obligations.
|
| |
| 2. |
We recognise that the unique philosophical and ethical implications of medical technology must be considered at all times.
|
| |
| 3. |
We respect the dignity, privacy and wellbeing of our patients and their families at all times.
|
| |
| 4. |
We will do our utmost to ensure all our patients, their families and the community are fully informed about the relevant benefits, risks and potential implications of VentrAssist™.
|
| |
| 5. |
We will ensure the scientific integrity of the clinical trials.
|
| |
| 6. |
We will support and work closely and effectively with our partner medical teams in conducting the clinical trials in the best possible environment.
|
| |
| 7. |
We will actively listen to and treat with the utmost respect, all stakeholders in an effort to understand their concerns and to help us progress in a responsible and timely way. |
More information
Shareholders and anyone interested in our progress can register here to receive our news updates.
|
